肥胖与2型糖尿病中循环卵泡抑素和激活素A及其受胰岛素调节
研究比较肥胖2型糖尿病(T2D)患者与糖耐量正常瘦者和肥胖者的血浆卵泡抑素(Fst)和激活素A水平,并观察4小时高胰岛素-正常血糖钳夹的影响。T2D患者循环Fst较瘦者和肥胖非糖尿病者高约30%(P < .001),激活素A无变化;急性高胰岛素血症使循环Fst降低约30%(P < .001),且该反应在T2D中保留;胰岛素抑制人肝细胞FST表达。
要点
- T2D患者循环Fst较瘦者和肥胖非糖尿病者高约30%(P < .001),激活素A无变化。
- 急性高胰岛素血症使循环Fst降低约30%(P < .001),该反应在T2D中保留。
- 空腹血浆Fst与胰岛素抵抗指标正相关,仅在T2D组中达显著(血糖除外)。
核心结论
- 循环Fst升高而非激活素A升高与T2D患者胰岛素抵抗指标强相关,但胰岛素抑制循环Fst的能力在T2D中保留。
研究设计与样本
- 研究分析肥胖T2D患者(N = 10)与糖耐量正常瘦者(N = 12)和肥胖者(N = 10)空腹及4小时高胰岛素-正常血糖钳夹(40 mU·m-2·min-1)联合间接测热法下的血浆Fst和激活素A水平。
主要发现
- T2D患者循环Fst较瘦者和肥胖非糖尿病者高约30%(P < .001),血浆激活素A无变化。
- 总队列中空腹血浆Fst与空腹血糖、血清胰岛素和C肽、胰岛素抵抗稳态模型评估、肝脏和脂肪组织胰岛素抵抗正相关(校正年龄、性别和组别后均r > 0.47;P < .05)。
- 上述相关性仅在T2D组中达显著(血浆葡萄糖除外)。
- 急性高胰岛素血症在正常血糖下使循环Fst降低约30%(P < .001),该反应在T2D患者中保留。
- 胰岛素抑制人肝细胞FST表达,2小时后抑制,48小时后进一步抑制。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Circulating follistatin (Fst) binds activin A and thereby regulates biological functions such as muscle growth and β-cell survival. However, Fst and activin A's implication in metabolic regulation is unclear. OBJECTIVE: To investigate circulating Fst and activin A in obesity and type 2 diabetes (T2D) and determine their association with metabolic parameters. Further, to examine regulation of Fst and activin A by insulin and the influence of obesity and T2D hereon. METHODS: Plasma Fst and activin A levels were analyzed in obese T2D patients (N = 10) closely matched to glucose-tolerant lean (N = 12) and obese (N = 10) individuals in the fasted state and following a 4-h hyperinsulinemic-euglycemic clamp (40 mU·m-2·min-1) combined with indirect calorimetry. RESULTS: Circulating Fst was ~30% higher in patients with T2D compared with both lean and obese nondiabetic individuals (P < .001), while plasma activin A was unaltered. In the total cohort, fasting plasma Fst correlated positively with fasting plasma glucose, serum insulin and C-peptide levels, homeostasis model assessment of insulin resistance, and hepatic and adipose tissue insulin resistance after adjusting for age, gender and group (all r > 0.47; P < .05). However, in the individual groups these correlations only achieved significance in patients with T2D (not plasma glucose). Acute hyperinsulinemia at euglycemia reduced circulating Fst by ~30% (P < .001) and this response was intact in patients with T2D. Insulin inhibited FST expression in human hepatocytes after 2 h and even further after 48 h. CONCLUSIONS: Elevated circulating Fst, but not activin A, is strongly associated with measures of insulin resistance in patients with T2D. However, the ability of insulin to suppress circulating Fst is preserved in T2D.
引用
- Sylow L, Vind BF, Kruse R, et al. Circulating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes. J Clin Endocrinol Metab. 2020. PMID: 32112102. doi:10.1210/clinem/dgaa090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。